Drugs / Dantonic
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01475279 | Jul → Nov 2011 | — | Tasly Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dantonic | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01475279 ↗ |
| Known as | T89 | “A Study to Evaluate the Effect of T89(Dantonic®)on Steady-State Pharmacodynamics of Warfarin” NCT01475279 ↗ |